Your browser doesn't support javascript.
loading
"All for One and One for All": The Secreted Heat Shock Protein gp96-Ig Based Vaccines.
Padula, Laura; Fisher, Eva; Strbo, Natasa.
Afiliação
  • Padula L; Department of Microbiology and Immunology, Miller School of Medicine, University of Miami, Miami, FL 33136, USA.
  • Fisher E; Department of Microbiology and Immunology, Miller School of Medicine, University of Miami, Miami, FL 33136, USA.
  • Strbo N; Department of Microbiology and Immunology, Miller School of Medicine, University of Miami, Miami, FL 33136, USA.
Cells ; 13(1)2023 12 29.
Article em En | MEDLINE | ID: mdl-38201276
ABSTRACT
It has been 50 years since Peter Charles Doherty and Rolf M Zinkernagel proposed the principle of "simultaneous dual recognition", according to which adaptive immune cells recognized "self" and "non-self" simultaneously to establish immunological efficacy. These two scientists shared the 1996 Nobel Prize in Physiology or Medicine for this discovery. Their basic immunological principle became the foundation for the development of numerous vaccine approaches against infectious diseases and tumors, including promising strategies grounded on the use of recombinant gp96-Ig developed by our lab over the last two decades. In this review, we will highlight three major principles of the gp96-Ig vaccine strategy (1) presentation of pathogenic antigens to T cells (specificity); (2) activation of innate immune responses (adjuvanticity); (3) priming of T cells to home to the epithelial compartments (mucosal immunity). In summary, we provide a paradigm for a vaccine approach that can be rapidly engineered and customized for any future pathogens that require induction of effective tissue-resident memory responses in epithelial tissues.
Assuntos
Palavras-chave

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Vacinas Idioma: En Revista: Cells Ano de publicação: 2023 Tipo de documento: Article País de afiliação: Estados Unidos

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Vacinas Idioma: En Revista: Cells Ano de publicação: 2023 Tipo de documento: Article País de afiliação: Estados Unidos